Earnings History Data for Graybug Vision, Inc. (GRAY) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Graybug Vision, Inc.

Graybug Vision Inc. is a clinical-stage biopharmaceutical company. It is focused on developing transformative medicines to treat chronic vision-threatening diseases of the retina and optic nerve. The company's product candidate includes GB-102, GB-401 and GB-103 which are in clinical stage. Graybug Vision Inc. is headquartered in Redwood City, California.

Release Date	Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
11-08-2022	PM	GRAY	Graybug Vision, Inc.	21.02	-0.38	-0.38	-0.36	Graybug Vision GAAP EPS of -$0.38 beats by $0.02 [8/11/2022 9:02 AM]	3.76	-0.21 (-5.29%)	1.02	0.01 (0.99%)	3.68 - 12.42	14,481	20,000	16,368
Graybug Vision GAAP EPS of -$0.38 beats by $0.02 [8/11/2022 9:02 AM] Graybug Vision Reports Financial Results for the Three and Six Months Ended June 30, 2022, and Recent Corporate Developments [Aug-11-22 07:30AM]
10-05-2022	AH	GRAY	Graybug Vision, Inc.	17.30	-0.48	-0.34	-0.54	Graybug Vision GAAP EPS of -$0.48 [5/10/2022 5:27 PM]	0.76	-0.06 (-6.75%)	0.82	0.01 (0.61%)	0.73 - 7.06	20,681	50,000	300
Graybug Vision GAAP EPS of -$0.48 [5/10/2022 5:27 PM] Graybug Vision Reports First Quarter 2022 Financial Results and Recent Corporate Developments [May-10-22 04:05PM]
12-05-2021	PM	GRAY	Graybug Vision, Inc.	90.00	-0.54	-0.45	0.00	Graybug Vision EPS misses by $0.08 [5/12/2021 7:47 AM]	4.11	-0.62 (-13.11%)	4.35	-0.38 (-8.03%)	3.95 - 37.88	1,282,922	690,000	389,616
Graybug Vision EPS misses by $0.08 [5/12/2021 7:47 AM] Graybug Vision reports full data from mid-stage wet AMD trial [5/12/2021 9:59 AM] Graybug Vision Announces First Quarter 2021 Financial Results and Recent Corporate Developments [May-12-21 07:30AM] Graybug Vision Reports Full-Data Analysis from 12-Month Treatment Phase of ALTISSIMO Phase 2b Trial in Wet AMD [May-12-21 07:00AM] Graybug Vision Reports Full Data Analysis After One Year Treatment Of GB-102 In Wet AMD [May-12-21 09:50AM]